Effects of evolocumab in individuals with type 2 diabetes with and without atherogenic dyslipidemia: An analysis from BANTING and BERSON
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2840
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Effects of evolocumab in individuals with type 2 diabetes with and without atherogenic dyslipidemia: An analysis from BANTING and BERSON ; volume:20 ; number:1 ; day:30 ; month:4 ; year:2021 ; pages:1-14 ; date:12.2021
Cardiovascular diabetology ; 20, Heft 1 (30.4.2021), 1-14, 12.2021
- Creator
-
Lorenzatti, Alberto J.
Monsalvo, Maria Laura
López, J. Antonio G.
Wang, Huei
Rosenson, Robert S.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12933-021-01287-6
- URN
-
urn:nbn:de:101:1-2021090619515479816460
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lorenzatti, Alberto J.
- Monsalvo, Maria Laura
- López, J. Antonio G.
- Wang, Huei
- Rosenson, Robert S.
- SpringerLink (Online service)
Other Objects (12)
Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional study
Search for genetic factors predisposing to atherogenic dyslipidemia
Cardiovascular risk profile of patients with atherogenic dyslipidemia in middle age Lithuanian population
Association between Atherogenic Dyslipidemia and Recurrent Stroke Risk in Patients with Different Subtypes of Ischemic Stroke
Prevalence and pattern of dyslipidemia in Nepalese individuals with type 2 diabetes
Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study
Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population
Prospects of potential adipokines as therapeutic agents in obesity-linked atherogenic dyslipidemia and insulin resistance
Assessment of Dyslipidemia, Lipid Ratios, and Atherogenic Indices as Cardiovascular Risk Factors in Prediabetic and Diabetic Subjects
The relation between atherogenic index of plasma and cardiovascular outcomes in prediabetic individuals with unstable angina pectoris
The association of dyslipidemia and obesity with glycated hemoglobin
Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional study
Search for genetic factors predisposing to atherogenic dyslipidemia
Cardiovascular risk profile of patients with atherogenic dyslipidemia in middle age Lithuanian population
Association between Atherogenic Dyslipidemia and Recurrent Stroke Risk in Patients with Different Subtypes of Ischemic Stroke
Prevalence and pattern of dyslipidemia in Nepalese individuals with type 2 diabetes
Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study
Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population
Prospects of potential adipokines as therapeutic agents in obesity-linked atherogenic dyslipidemia and insulin resistance
Assessment of Dyslipidemia, Lipid Ratios, and Atherogenic Indices as Cardiovascular Risk Factors in Prediabetic and Diabetic Subjects
The relation between atherogenic index of plasma and cardiovascular outcomes in prediabetic individuals with unstable angina pectoris
The association of dyslipidemia and obesity with glycated hemoglobin
Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional study
Search for genetic factors predisposing to atherogenic dyslipidemia
Cardiovascular risk profile of patients with atherogenic dyslipidemia in middle age Lithuanian population
Association between Atherogenic Dyslipidemia and Recurrent Stroke Risk in Patients with Different Subtypes of Ischemic Stroke
Prevalence and pattern of dyslipidemia in Nepalese individuals with type 2 diabetes
Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study
Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population
Prospects of potential adipokines as therapeutic agents in obesity-linked atherogenic dyslipidemia and insulin resistance
Assessment of Dyslipidemia, Lipid Ratios, and Atherogenic Indices as Cardiovascular Risk Factors in Prediabetic and Diabetic Subjects
The relation between atherogenic index of plasma and cardiovascular outcomes in prediabetic individuals with unstable angina pectoris